Literature DB >> 1484394

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine.

F R Sharp1, M Butman, S Wang, J Koistinaho, S H Graham, S M Sagar, L Noble, P Berger, F M Longo.   

Abstract

The non-competitive NMDA receptor antagonists, PCP (phencyclidine), MK801, and ketamine produce psychosis in humans and abnormal vacuoles in posterior cingulate and retrosplenial rat cortical neurons. We show that PCP (> or = 5 mg/kg), MK801 (> or = 0.1 mg/kg), and ketamine (> 20 mg/kg) induce hsp70 mRNA and HSP70 heat shock protein in these vacuolated, injured neurons, and PCP also induces hsp70 in injured neocortical, piriform, and amygdala neurons. The PCP, MK801, and ketamine drug induced injury occurs in 30 day and older rats, but not in 0-20 day old rats, and is prevented by prior administration of the antipsychotic drugs haloperidol and rimcazole. Since haloperidol and rimcazole block dopamine and sigma receptors, and since M1 muscarinic cholinergic receptor antagonists also prevent the injury produced by PCP, MK801, and ketamine, future studies will be needed to determine whether dopamine, sigma, M1, or other receptors mediate the injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484394     DOI: 10.1002/jnr.490330413

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

1.  MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain.

Authors:  X M Gao; C A Tamminga
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Postweaning social isolation exacerbates neurotoxic effects of the NMDA receptor antagonist MK-801 in rats.

Authors:  Dragos Inta; Peter Renz; Juan M Lima-Ojeda; Christof Dormann; Peter Gass
Journal:  J Neural Transm (Vienna)       Date:  2013-06-05       Impact factor: 3.575

3.  Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill; L L Iversen
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

4.  Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate).

Authors:  A S Fix; J W Horn; L L Truex; R A Smith; E Gomez
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

Authors:  Xue-Min Gao; Gregory I Elmer; Beverley Adams-Huet; Carol A Tamminga
Journal:  Pharmacol Biochem Behav       Date:  2008-12-10       Impact factor: 3.533

6.  Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Carla M Yuede; Carolyn Coughlan; Brian Lewis; John G Csernansky
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

Review 7.  Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?

Authors:  Frank R Sharp; Robert L Hendren
Journal:  Epilepsy Behav       Date:  2007-04-06       Impact factor: 2.937

8.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

9.  A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801.

Authors:  Patrick J Morris; Richard D Burke; Alok K Sharma; Daniel C Lynch; Leslie E Lemke-Boutcher; Shiny Mathew; Ikram Elayan; Deepa B Rao; Todd D Gould; Carlos A Zarate; Panos Zanos; Ruin Moaddel; Craig J Thomas
Journal:  Neurotoxicol Teratol       Date:  2021-05-01       Impact factor: 4.071

10.  Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting.

Authors:  Yuchun Zhang; Rodolfo R Llinas; John E Lisman
Journal:  Front Neural Circuits       Date:  2009-11-10       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.